Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Census population 255,205. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Laredo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Laredo storefront.
Wound Care Dressing Products for Healthcare Providers in Laredo, TX for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Census city-proper population is 255,205. If you are adding wound care dressing products, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Wound Care Dressing Products for Healthcare Providers notes (how the product actually works)CDC PLACES (2023, crude) estimates 16.4% of adults in Laredo have diagnosed diabetes — 4.4 points above the U.S. 12% figure. Adult obesity in Laredo is 42.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 18.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 35.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 16.4% of adults — 4.4 points above the U.S. 12% figure. Obesity is 42.2%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Laredo trial.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Texas is in CMS MAC JH, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
No. They are B2B distribution pages for licensed providers. Patients in Laredo should speak with their clinician, not use a distributor URL as care instructions.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Laredo fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Laredo, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Laredo is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Laredo — 4.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Laredo. Useful for joint-program math; still needs a diagnosis and privileging.
No Laredo storefront. Joe Bradley is an active practice owner. wound care dressing products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.